🔎 Trials Near Me

Home › Seizures › Florida › Miami

Seizures clinical trials in Miami, FL

6 studies for Seizures are looking for participants at sites in and around Miami (within about 30 miles). Open a study to see who can join and how to contact the study team.

Recruiting for a study here? Feature it at the top of this page — $99 for 30 days →

An Efficacy and Safety Study of Clemizole HCl in Patients With Lennox-Gastaut Syndrome

RecruitingPhase 3
  • University of Miami Miller School of Medicine, Miami
Ages 2 to 55 · All sexes · Updated Oct 2, 2026 · NCT05066217

RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures

RecruitingPhase 2
  • Visionary Investigators Network, Miami
  • University of Miami, Miami
Ages 18 to 70 · All sexes · Updated Oct 1, 2026 · NCT06798896

Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures

RecruitingPhase 3
  • Serenity Research Center, LLC, Miami
Ages 18 to 75 · All sexes · Updated Sep 2, 2026 · NCT07594119

Study of NRTX-1001 Neural Cell Therapy in Drug-Resistant Unilateral Mesial Temporal Lobe Epilepsy (EPIC (EPIlepsy Cell Therapy))

RecruitingPhase 3
  • University of Miami, Miami
Ages 18 to 75 · All sexes · Updated Jun 9, 2026 · NCT05135091

Safety and Tolerability Study of SPN-817 in Adult Patients With Treatment Resistant Epilepsy

RecruitingPhase 2
  • Visionary Investigators Network, Miami
Ages 18 to 70 · All sexes · Updated Apr 21, 2026 · NCT05518578

Methylphenidate for the Treatment of Epilepsy-related Cognitive Deficits

RecruitingPhase 4Healthy volunteers welcome
  • Miami VA Healthcare System, Miami, FL, Miami
Ages 18 and older · All sexes · Updated Apr 20, 2026 · NCT04419272

About Seizures

Seizures are caused by sudden, abnormal electrical activity in the brain. They can be mild or severe. Learn about the types, causes, and treatments.

More about Seizures on MedlinePlus

Seizures trials in other cities

Other studies in Miami

From ClinicalTrials.gov, data retrieved Oct 5, 2026. Each study sets its own eligibility; the study team decides who can join.